{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:46:14Z","timestamp":1785883574762,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Abnormal phosphate homeostasis is associated with inflammation, vascular calcification, and endothelial dysfunction in chronic kidney disease (CKD). Apparent treatment-resistant hypertension (ATRH) is common in CKD and is associated with increased cardiovascular mortality. We examined the associations between phosphate homeostasis-related biomarkers and ATRH in patients with CKD. The Chronic Renal Insufficiency Cohort (CRIC) Study enrolled 3939 participants with CKD in the United States between 2003 and 2008. After excluding those with missing ATRH data, 3752 were analyzed. ATRH was defined as blood pressure (BP)\u2009\u2265\u2009140\/90\u2009mm Hg while taking \u22653 antihypertensive medications, or BP\u2009&lt;\u2009140\/90\u2009mm Hg while taking \u22654 medications. In addition to phosphate homeostasis-related biomarkers, we calculated the phosphate burden index as the combined effect of phosphate retention on circulation and bone metabolism: index =\n                    <jats:italic>serum phosphate \u00d7 parathyroid hormone<\/jats:italic>\n                    . Elastic Net and multivariable regression models assessed associations between phosphate biomarkers and ATRH. Participants with ATRH were older and more often male and Black. The adjusted odds ratios (95% confidence intervals) for the highest quartiles compared with the lowest quartile were 1.42 (1.09\u20131.86) for serum phosphate, 1.48 (1.15\u20131.91) for the urine phosphate-to-creatinine ratio, and 2.30 (1.72\u20133.08) for phosphate burden index. These associations were also significant in linear regression models for the urine phosphate-to-creatinine ratio and the phosphate burden index. We conclude that higher levels of phosphate-related biomarkers are independently associated with ATRH. Future studies should investigate whether targeting abnormal phosphate homeostasis can reduce ATRH risk in patients with CKD.\n                  <\/jats:p>","DOI":"10.1038\/s41440-026-02706-5","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:48:09Z","timestamp":1781668089000},"page":"2404-2416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phosphate homeostasis and apparent treatment-resistant hypertension in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study"],"prefix":"10.1038","volume":"49","author":[{"given":"Alvin G.","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Lee","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Alper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil K.","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suayp","family":"Oygen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Bundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the CRIC Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Dember","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Lee","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panduranga S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2706_CR1","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2215\/CJN.00550113","volume":"8","author":"RM Tanner","year":"2013","unstructured":"Tanner RM, Calhoun DA, Bell EK, Bowling CB, Guti\u00e9rrez OM, Irvin MR, et al. Prevalence of apparent treatment-resistant hypertension among individuals with CKD. Clin J Am Soc Nephrol. 2013;8:1583\u201390.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2706_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.115.06487","volume":"67","author":"G Thomas","year":"2016","unstructured":"Thomas G, Xie D, Chen H-Y, Anderson AH, Appel LJ, Bodana S, et al. Prevalence and prognostic significance of apparent treatment-resistant hypertension in chronic kidney disease: report from the Chronic Renal Insufficiency Cohort Study. Hypertension. 2016;67:387\u201396.","journal-title":"Hypertension"},{"key":"2706_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/HYPERTENSIONAHA.114.03565","volume":"64","author":"KM Diaz","year":"2014","unstructured":"Diaz KM, Booth JN, Calhoun DA, Irvin MR, Howard G, Safford MM, et al. Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the reasons for geographic and racial differences in stroke study. Hypertension. 2014;64:465\u201371.","journal-title":"Hypertension"},{"key":"2706_CR4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","volume":"57","author":"SD Persell","year":"2011","unstructured":"Persell SD. Prevalence of resistant hypertension in the United States, 2003\u20132008. Hypertension. 2011;57:1076\u201380.","journal-title":"Hypertension"},{"key":"2706_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1053\/j.ackd.2014.08.006","volume":"21","author":"S Vemulapalli","year":"2014","unstructured":"Vemulapalli S, Tyson CC, Svetkey LP. Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome? Adv Chronic Kidney Dis. 2014;21:489\u201399.","journal-title":"Adv Chronic Kidney Dis"},{"key":"2706_CR6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000488255","volume":"43","author":"F Viazzi","year":"2018","unstructured":"Viazzi F, Greco E, Ceriello A, Fioretto P, Giorda C, Guida P, et al. Apparent treatment-resistant hypertension, blood pressure control and the progression of chronic kidney disease in patients with type 2 diabetes. Kidney Blood Press Res. 2018;43:422\u201338.","journal-title":"Kidney Blood Press Res"},{"key":"2706_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ekir.2016.10.006","volume":"2","author":"J Kabor\u00e9","year":"2017","unstructured":"Kabor\u00e9 J, Metzger M, Helmer C, Berr C, Tzourio C, Drueke TB, et al. Hypertension control, apparent treatment resistance, and outcomes in the elderly population with chronic kidney disease. Kidney Int Rep. 2017;2:180\u201391.","journal-title":"Kidney Int Rep"},{"key":"2706_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.ajkd.2019.07.022","volume":"75","author":"T Isakova","year":"2020","unstructured":"Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, et al. Longitudinal evolution of markers of mineral metabolism in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2020;75:235\u201344.","journal-title":"Am J Kidney Dis"},{"key":"2706_CR9","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79:1370\u20138.","journal-title":"Kidney Int"},{"key":"2706_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.akdh.2022.12.011","volume":"30","author":"I Portales-Castillo","year":"2023","unstructured":"Portales-Castillo I, Rieg T, Khalid SB, Nigwekar SU, Neyra JA. Physiopathology of phosphate disorders. Adv Kidney Dis Health. 2023;30:177\u201388.","journal-title":"Adv Kidney Dis Health"},{"key":"2706_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"G Block","year":"1998","unstructured":"Block G, Hulbert-Shearon T, Levin N, Port F. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607\u201317.","journal-title":"Am J Kidney Dis"},{"key":"2706_CR12","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1097\/HJH.0000000000000261","volume":"32","author":"M Bozic","year":"2014","unstructured":"Bozic M, Panizo S, Sevilla MA, Riera M, Soler MJ, Pascual J, et al. High-phosphate diet increases arterial blood pressure via a parathyroid hormone-mediated increase of renin. J Hypertens. 2014;32:1822\u201332.","journal-title":"J Hypertens"},{"key":"2706_CR13","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1152\/ajpregu.00124.2016","volume":"311","author":"M Mizuno","year":"2016","unstructured":"Mizuno M, Mitchell JH, Crawford S, Huang C-L, Maalouf N, Hu M-C, et al. High dietary phosphate intake induces hypertension and augments exercise pressor reflex function in rats. Am J Physiol Regul Integr Comp Physiol. 2016;311:R39\u2013R48.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2706_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.124.071605","volume":"152","author":"H-K Kim","year":"2025","unstructured":"Kim H-K, Fukazawa A, Smith SA, Mizuno M, Rothermel BA, Fujikawa T, et al. High dietary phosphate intake induces hypertension and sympathetic overactivation via central fibroblast growth factor receptor signaling. Circulation. 2025;152:450\u201364.","journal-title":"Circulation"},{"key":"2706_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3164\/jcbn.11-96","volume":"51","author":"TV Van","year":"2012","unstructured":"Van TV, Watari E, Taketani Y, Kitamura T, Shiota A, Tanaka T, et al. Dietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats. J Clin Biochem Nutr. 2012;51:27\u201332.","journal-title":"J Clin Biochem Nutr"},{"key":"2706_CR16","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1681\/ASN.2008101106","volume":"20","author":"E Shuto","year":"2009","unstructured":"Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009;20:1504\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"2706_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/MNH.0000000000001002","volume":"33","author":"S Bansal","year":"2024","unstructured":"Bansal S. Revisiting resistant hypertension in kidney disease. Curr Opin Nephrol Hypertens. 2024;33:465\u201373.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2706_CR18","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/HJH.0000000000000936","volume":"34","author":"AL Fyfe-Johnson","year":"2016","unstructured":"Fyfe-Johnson AL, Alonso A, Selvin E, Bower JK, Pankow JS, Agarwal SK, et al. Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. J Hypertens. 2016;34:1266\u201372.","journal-title":"J Hypertens"},{"key":"2706_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.118.11060","volume":"72","author":"E Akhabue","year":"2018","unstructured":"Akhabue E, Montag S, Reis JP, Pool LR, Mehta R, Yancy CW, et al. FGF23 (Fibroblast Growth Factor-23) and incident hypertension in young and middle-aged adults: the CARDIA study. Hypertension. 2018;72:70\u201376.","journal-title":"Hypertension"},{"key":"2706_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pbj.2017.02.005","volume":"2","author":"M Mendes","year":"2017","unstructured":"Mendes M, Resende L, Teixeira A, Correia J, Silva G. Blood pressure and phosphate level in diabetic and non-diabetic kidney disease: Results of the cross-sectional \u201cLow Clearance Consultation\u201d study. Porto Biomed J. 2017;2:301\u20135.","journal-title":"Porto Biomed J"},{"key":"2706_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1681\/ASN.2008040349","volume":"20","author":"KL Adeney","year":"2009","unstructured":"Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20:381\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"2706_CR22","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/S0140-6736(15)60325-7","volume":"385","author":"KK Stevens","year":"2015","unstructured":"Stevens KK, Patel RK, Mark PB, Delles C, Jardine AG. Phosphate as a cardiovascular risk factor: effects on vascular and endothelial function. Lancet. 2015;385:S10.","journal-title":"Lancet"},{"key":"2706_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/CS20190895","volume":"135","author":"J Voelkl","year":"2021","unstructured":"Voelkl J, Egli-Spichtig D, Alesutan I, Wagner CA. Inflammation: a putative link between phosphate metabolism and cardiovascular disease. Clin Sci. 2021;135:201\u201327.","journal-title":"Clin Sci"},{"key":"2706_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5551\/jat.RV17045","volume":"28","author":"M Kuro-o","year":"2021","unstructured":"Kuro-o M. Phosphate as a pathogen of arteriosclerosis and aging. JAT. 2021;28:203\u201313.","journal-title":"JAT"},{"key":"2706_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2018.02.009","volume":"271","author":"JD Bundy","year":"2018","unstructured":"Bundy JD, Chen J, Yang W, Budoff M, Go AS, Grunwald JE, et al. Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: the CRIC study. Atherosclerosis. 2018;271:53\u201360.","journal-title":"Atherosclerosis"},{"key":"2706_CR26","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2215\/CJN.00070109","volume":"4","author":"JP Lash","year":"2009","unstructured":"Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, et al. Chronic Renal Insufficiency Cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009;4:1302\u201311.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2706_CR27","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","volume":"14","author":"HI Feldman","year":"2003","unstructured":"Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, et al. The Chronic Renal Insufficiency Cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003;14:S148\u2013S153.","journal-title":"J Am Soc Nephrol"},{"key":"2706_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/HYPERTENSIONAHA.118.12358","volume":"73","author":"J Chen","year":"2019","unstructured":"Chen J, Bundy JD, Hamm LL, Hsu C, Lash J, Miller ER, et al. Inflammation and apparent treatment-resistant hypertension in patients with chronic kidney disease: the results from the CRIC Study. Hypertension. 2019;73:785\u201393.","journal-title":"Hypertension"},{"key":"2706_CR29","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C\u2013based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349.","journal-title":"N Engl J Med"},{"key":"2706_CR30","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1161\/HYP.0000000000000249","volume":"82","author":"DW Jones","year":"2025","unstructured":"Writing Committee Members*, Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension. 2025;82:e212\u2013e316.","journal-title":"Hypertension"},{"key":"2706_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-91623-7_1","volume":"1362","author":"MS Razzaque","year":"2022","unstructured":"Razzaque MS. Phosphate metabolism: from physiology to toxicity. Adv Exp Med Biol. 2022;1362:1\u20136.","journal-title":"Adv Exp Med Biol"},{"key":"2706_CR32","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/nu15051236","volume":"15","author":"M Wang","year":"2023","unstructured":"Wang M, Zhang J, Kalantar-Zadeh K, Chen J. Focusing on phosphorus loads: from healthy people to chronic kidney disease. Nutrients. 2023;15:1236.","journal-title":"Nutrients"},{"key":"2706_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ejhg.2010.165","volume":"19","author":"R Moonesinghe","year":"2011","unstructured":"Moonesinghe R, Khoury MJ, Liu T, Janssens AC. Discriminative accuracy of genomic profiling comparing multiplicative and additive risk models. Eur J Hum Genet. 2011;19:180\u20135.","journal-title":"Eur J Hum Genet"},{"key":"2706_CR34","doi-asserted-by":"publisher","first-page":"e0250282","DOI":"10.1371\/journal.pone.0250282","volume":"16","author":"LM Diaz-Gallo","year":"2021","unstructured":"Diaz-Gallo LM, Brynedal B, Westerlind H, Sandberg R, Ramsk\u00f6ld D. Understanding interactions between risk factors and assessing the utility of the additive and multiplicative models through simulations. PLoS One. 2021;16:e0250282.","journal-title":"PLoS One"},{"key":"2706_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Ser B Stat Methodol. 2005;67:301\u201320.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"2706_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","volume":"6","author":"A Covic","year":"2018","unstructured":"Covic A, Vervloet M, Massy ZA, Torres PU, Goldsmith D, Brandenburg V, et al. Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diab Endocrinol. 2018;6:319\u201331.","journal-title":"Lancet Diab Endocrinol"},{"key":"2706_CR37","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1001\/archinte.1991.00400080083015","volume":"151","author":"C G\u00f6k\u00e7e","year":"1991","unstructured":"G\u00f6k\u00e7e C, G\u00f6k\u00e7e O, Baydin\u00e7 C, Ilhan N, Ala\u015fehirli E, Ozk\u00fc\u00e7\u00fck F, et al. Use of random urine samples to estimate total urinary calcium and phosphate excretion. Arch Intern Med. 1991;151:1587\u20138.","journal-title":"Arch Intern Med"},{"key":"2706_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/jhh.2010.91","volume":"25","author":"SG Lakoski","year":"2011","unstructured":"Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, et al. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens. 2011;25:73\u201379.","journal-title":"J Hum Hypertens"},{"key":"2706_CR39","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1161\/01.ATV.0000041842.43905.F3","volume":"22","author":"G Engstr\u00f6m","year":"2002","unstructured":"Engstr\u00f6m G, Janzon L, Berglund G, Lind P, Stavenow L, Hedblad B, et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. ATVB. 2002;22:2054\u20138.","journal-title":"ATVB"},{"key":"2706_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2011.04.024","volume":"58","author":"MJ Budoff","year":"2011","unstructured":"Budoff MJ, Rader DJ, Reilly MP, Mohler ER, Lash J, Yang W, et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis. 2011;58:519\u201326.","journal-title":"Am J Kidney Dis"},{"key":"2706_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/ndt\/gfm660","volume":"23","author":"ND Toussaint","year":"2007","unstructured":"Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transpl. 2007;23:586\u201393.","journal-title":"Nephrol Dial Transpl"},{"key":"2706_CR42","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.ekir.2021.05.012","volume":"6","author":"SM Sprague","year":"2021","unstructured":"Sprague SM, Martin KJ, Coyne DW. Phosphate balance and CKD\u2013mineral bone disease. Kidney Int Rep. 2021;6:2049\u201358.","journal-title":"Kidney Int Rep"},{"key":"2706_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/HJH.0000000000000021","volume":"32","author":"A Yannoutsos","year":"2014","unstructured":"Yannoutsos A, Levy BI, Safar ME, Slama G, Blacher J. Pathophysiology of hypertension: interactions between macro and microvascular alterations through endothelial dysfunction. J Hypertens. 2014;32:216\u201324.","journal-title":"J Hypertens"},{"key":"2706_CR44","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.xkme.2021.05.008","volume":"3","author":"J Qian","year":"2021","unstructured":"Qian J, Zhong J, Liu S, Yan M, Cheng P, Hao C, et al. \u03b1-Klotho, plasma asymmetric dimethylarginine, and kidney disease progression. Kidney Med. 2021;3:984\u2013991.e1.","journal-title":"Kidney Med"},{"key":"2706_CR45","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2215\/CJN.00010108","volume":"3","author":"S Kobayashi","year":"2008","unstructured":"Kobayashi S, Oka M, Maesato K, Ikee R, Mano T, Hidekazu M, et al. Coronary artery calcification, ADMA, and insulin resistance in CKD patients. Clin J Am Soc Nephrol. 2008;3:1289\u201395.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2706_CR46","doi-asserted-by":"publisher","first-page":"7768","DOI":"10.3390\/ijms22157768","volume":"22","author":"MA Lacerda-Abreu","year":"2021","unstructured":"Lacerda-Abreu MA, Meyer-Fernandes JR. Extracellular inorganic phosphate-induced release of reactive oxygen species: roles in physiological processes and disease development. IJMS. 2021;22:7768.","journal-title":"IJMS"},{"key":"2706_CR47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/antiox14040461","volume":"14","author":"MA Lacerda-Abreu","year":"2025","unstructured":"Lacerda-Abreu MA, Meyer-Fernandes JR. Hyperphosphataemia and NADPH oxidase regulation in pathophysiological processes: implications for oxidative stress and disease progression. Antioxidants. 2025;14:461.","journal-title":"Antioxidants"},{"key":"2706_CR48","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.freeradbiomed.2010.06.029","volume":"49","author":"Y-L Tain","year":"2010","unstructured":"Tain Y-L, Kao Y-H, Hsieh C-S, Chen C-C, Sheen J-M, Lin I-C, et al. Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine. Free Radic Biol Med. 2010;49:1088\u201398.","journal-title":"Free Radic Biol Med"},{"key":"2706_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12882-022-02918-0","volume":"23","author":"J Jung","year":"2022","unstructured":"Jung J, Jeon-Slaughter H, Nguyen H, Patel J, Sambandam KK, Shastri S, et al. Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive hemodialysis patients. BMC Nephrol. 2022;23:291.","journal-title":"BMC Nephrol"},{"key":"2706_CR50","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1097\/HJH.0000000000000659","volume":"33","author":"RK Patel","year":"2015","unstructured":"Patel RK, Jeemon P, Stevens KK, Mccallum L, Hastie CE, Schneider A, et al. Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults. J Hypertens. 2015;33:2046\u201353.","journal-title":"J Hypertens"},{"key":"2706_CR51","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1053\/j.ajkd.2013.04.010","volume":"62","author":"X Hui","year":"2013","unstructured":"Hui X, Matsushita K, Sang Y, Ballew SH, F\u00fcl\u00f6p T, Coresh J. CKD and cardiovascular disease in the atherosclerosis risk in communities (ARIC) Study: interactions with age, sex, and race. Am J Kidney Dis. 2013;62:691\u2013702.","journal-title":"Am J Kidney Dis"},{"key":"2706_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31\u201338.","journal-title":"Kidney Int"},{"key":"2706_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99123","volume":"3","author":"JE Blau","year":"2018","unstructured":"Blau JE, Bauman V, Conway EM, Piaggi P, Walter MF, Wright EC, et al. Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight. 2018;3:e99123.","journal-title":"JCI Insight"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02706-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:02:32Z","timestamp":1785880952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02706-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2706"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02706-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}